r.szabo
TL2 Moderator · Beirut
Contributes reviews on supplier material. Based in Beirut.
Joined 30 December 2024 · last posted 9d
78 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #44 · Access › Insurance & coverage · 19 Jul 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Packaging that arrived damaged: documenting it properly Replied, post #42 · Sourcing › Logistics · 14 Jul 2026 · 0 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Journal club: what we got wrong in an earlier session Replied, post #74 · Evidence › Journal club · 11 Jul 2026 · 22 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
How to ask a question when you cannot say why you are asking it Replied, post #37 · Start Here › How to Ask · 11 Jul 2026 · 21 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Alcohol: what is documented and what is folklore Replied, post #100 · Practice › Interactions · 8 Jul 2026 · 1 like Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Revisiting: The best-written scientific paper you have read Replied, post #57 · Lounge › Off topic · 28 Jun 2026 · 5 likes On post #53 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Constipation management, with a dietitian's contribution Replied, post #83 · Practice › Side effects · 24 Jun 2026 · 27 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
What published stability data actually covers, and what it does not Replied, post #5 · Practice › Storage & stability · 7 Jun 2026 · 0 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #44 · Practice › Storage & stability · 1 Jun 2026 · 5 likes post #43 is right about the mechanism and I think understates the practical bit. Container choice matters: the material of the vial, the rubber closure, the fill volume…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #59 · Practice › Reconstitution · 26 May 2026 · 0 likes post #58 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Transporting a vial for a weekend away — a second dataset Replied, post #61 · Practice › Storage & stability · 23 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #23 · Analytics › Home & field testing · 20 May 2026 · 21 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #10 · Practice › Side effects · 12 May 2026 · 3 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #2 · Pharmacology › Pharmacokinetics · 9 May 2026 · 17 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #56 · Practice › Administration · 9 May 2026 · 11 likes post #55 is right about the mechanism and I think understates the practical bit. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #21 · Practice › Reconstitution · 18 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
List price versus negotiated price versus what you pay Replied, post #111 · Access › Pricing · 17 Apr 2026 · 17 likes post #110 is right about the mechanism and I think understates the practical bit. Insurance tier placement: a compound might be covered but on a higher tier (higher…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #101 · Practice › Reconstitution · 16 Apr 2026 · 3 likes Picking up post #98: that is the part I would want checked first. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #11 · Practice › Dosing & titration · 15 Apr 2026 · 10 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #78 · Practice › Reconstitution · 28 Mar 2026 · 21 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Grapefruit: why this class is not the class that cares Replied, post #71 · Practice › Interactions · 23 Mar 2026 · 21 likes This follows post #68 rather than contradicting it. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #35 · Lounge › Introductions · 11 Mar 2026 · 19 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #68 · Start Here › How to Ask · 27 Feb 2026 · 18 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #36 · Sourcing › Logistics · 10 Feb 2026 · 18 likes post #35 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #21 · Outcomes › Progress reports · 8 Feb 2026 · 14 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #81 · Access › Pricing · 5 Feb 2026 · 8 likes I read post #79 twice before replying, because I had assumed the opposite. Biosimilars and future generics: as patents expire, biosimilar and generic versions might…
-
When to stop reading forums, including this one Replied, post #80 · Wellbeing › Mental health · 24 Jan 2026 · 5 likes Coming back to post #78, because the follow-up matters more than the original answer. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #21 · Research Methods › N-of-1 designs · 16 Jan 2026 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Waist circumference technique and its repeatability Replied, post #36 · Outcomes › Progress reports · 8 Jan 2026 · 0 likes Worth separating two things that post #32 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: What to keep a record of at the point of payment Started this topic · Sourcing › Payments · 4 Jan 2026 · 0 likes Second pass at: What to keep a record of at the point of payment — setting out what I have, and where I think it stops being reliable. A logistics question, since the…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #82 · Practice › Interactions · 3 Jan 2026 · 1 like Worth separating two things that post #78 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #30 · Sourcing › Vendor reports · 2 Jan 2026 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Temporal patterns: if results from a supplier were good two years ago but have deteriorated…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #30 · Sourcing › Red flags · 29 Dec 2025 · 25 likes Picking up post #27: that is the part I would want checked first. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes…
-
Tracking a preprint to publication: a worked example Replied, post #3 · Evidence › Preprints · 28 Nov 2025 · 27 likes Coming back to the opening post, because the follow-up matters more than the original answer. Unrefereed work is not worthless. A great deal of it survives review…
-
Pen dose counters: what a click does and does not guarantee Replied, post #32 · Devices › Pens & autoinjectors · 14 Nov 2025 · 1 like Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
Thyroid function tests during substantial weight change Replied, post #115 · Clinical › Bloodwork · 30 Oct 2025 · 22 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
A 40-week log with the measurement method stated Replied, post #3 · Outcomes › Progress reports · 12 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #44 · Analytics › COA interpretation · 30 Sep 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #47 · Practice › Storage & stability · 21 Sep 2025 · 11 likes On post #43 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #8 · Sourcing › Regulatory · 20 Sep 2025 · 0 likes post #7 is right about the mechanism and I think understates the practical bit. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #11 · Clinical › Bloodwork · 19 Sep 2025 · 23 likes On post #7 — agreed on the reasoning, with one qualification. A single value outside interval: usually uninformative on a single draw. What makes a result interesting:…
-
Revisiting: Power cut for eleven hours: how I assessed it afterwards Started this topic · Practice › Storage & stability · 17 Sep 2025 · 50 likes Revisiting: Power cut for eleven hours: how I assessed it afterwards — setting out what I have, and where I think it stops being reliable. A question about technique…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #14 · Data & Tools › Datasets · 6 Sep 2025 · 19 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
An emergency department visit, described afterwards Replied, post #62 · Safety › Adverse events · 3 Sep 2025 · 16 likes Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3× upper limit of normal). If this constellation appears,…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #68 · Compounds › Secretagogues & GH axis · 16 Aug 2025 · 0 likes post #67 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #26 · Pharmacology › Receptor biology · 11 Aug 2025 · 13 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Asking about a compound your prescriber has not heard of Replied, post #122 · Clinical › Prescriber conversations · 11 Aug 2025 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #3 · Compounds › Semaglutide · 23 Jul 2025 · 5 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
[2026 update] Constipation management, with a dietitian's contribution Replied, post #11 · Practice › Side effects · 16 Jul 2025 · 22 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #41 · Practice › Dosing & titration · 13 Jul 2025 · 12 likes This follows post #38 rather than contradicting it. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #18 · Compounds › Semaglutide · 5 Jul 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #74 · Practice › Storage & stability · 28 Jun 2025 · 13 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #8 · Compounds › Secretagogues & GH axis · 14 Jun 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #84 · Access › Insurance & coverage · 12 Jun 2025 · 7 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 4 Jun 2025 · 2 likes post #9 answers the question as asked. The question underneath it is different. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
Publishing an inconvenient result: a case study Replied, post #26 · Sourcing › Independent verification · 28 May 2025 · 22 likes Worth separating two things that post #22 runs together. How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity,…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #67 · Compounds › Secretagogues & GH axis · 22 May 2025 · 20 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pregnancy as an absolute contraindication Replied, post #82 · Safety › Contraindications · 20 May 2025 · 26 likes post #81 answers the question as asked. The question underneath it is different. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #39 · Clinical › Comorbidities · 13 May 2025 · 0 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Follow-up: What other technical communities get right that we do not Replied, post #94 · Lounge › Off topic · 11 May 2025 · 10 likes Coming back to post #92, because the follow-up matters more than the original answer. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no…
-
Revisiting: Filing a first vendor report: a worked example Started this topic · Sourcing › Vendor reports · 8 May 2025 · 8 likes On the subject in the title: Revisiting: Filing a first vendor report: a worked example Working notes rather than a conclusion. Structured report rather than an…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #36 · Data & Tools › Calculators · 27 Apr 2025 · 10 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
A newcomer's list of things that confused me, and the fixes Replied, post #9 · Start Here › Welcome · 20 Apr 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #52 · Practice › Reconstitution · 17 Apr 2025 · 6 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Publishing an inconvenient result: a case study Replied, post #7 · Sourcing › Independent verification · 11 Apr 2025 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Scheduled maintenance and what will be unavailable Replied, post #96 · Meta › Announcements · 3 Apr 2025 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #87 · Evidence › Meta-analyses · 10 Feb 2025 · 5 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #4 · Wellbeing › Mental health · 8 Feb 2025 · 27 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
Isotonicity and what happens when you get it wrong Replied, post #17 · Pharmacology › Formulation chemistry · 4 Jan 2025 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. Container closure: the vial material, rubber closure, and sealing all affect permeability to…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #16 · Compounds › Oral incretins · 3 Jan 2025 · 2 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Revisiting: Moderation log format change Replied, post #61 · Meta › Announcements · 9 Dec 2024 · 6 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Why "any advice?" is the least effective ending for a post Replied, post #98 · Start Here › How to Ask · 2 Dec 2024 · 22 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #132 · Analytics › COA interpretation · 28 Nov 2024 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #42 · Clinical › Prescriber conversations · 8 Nov 2024 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #11 · Practice › Interactions · 25 Sep 2024 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Promotion criteria, and the one that stops most nominations Replied, post #48 · Documentation › Doc review · 28 Aug 2024 · 1 like This follows post #45 rather than contradicting it. Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so…
-
Cold packs, phase-change material, and what survives ten days Replied, post #114 · Sourcing › Logistics · 17 Jul 2024 · 29 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Assessing a warm arrival: the decision process — one year on Replied, post #132 · Sourcing › Logistics · 2 Jun 2024 · 22 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…